Abstract
Background
Diabetes mellitus has become a worldwide health problem. Whether fruit juice is beneficial in glycemic control is still inconclusive. This study aimed to synthesize evidence from randomized controlled trials on fruit juice in relationship to glucose control and insulin sensitivity.
Methods
A strategic literature search of PubMed, EMBASE, and the Cochrane Library (updated to March, 2014) was performed to retrieve the randomized controlled trials that evaluated the effects of fruit juice on glucose control and insulin sensitivity. Study quality was assessed using the Jadad scale. Weighted mean differences were calculated for net changes in the levels of fasting glucose, fasting insulin, hemoglobin A1c (HbA1c), and homeostatic model assessment of insulin resistance (HOMA-IR) using fixed- or random-effects model. Prespecified subgroup and sensitivity analyses were performed to explore the potential heterogeneity.
Results
Twelve trials comprising a total of 412 subjects were included in the current meta-analysis. The numbers of these studies that reported the data on fasting glucose, fasting insulin, HbA1c and HOMA-IR were 12, 5, 3 and 3, respectively. Fruit juice consumption did not show a significant effect on fasting glucose and insulin concentrations. The net change was 0.79 mg/dL (95% CI: −1.44, 3.02 mg/dL; P = 0.49) for fasting glucose concentrations and −0.74 µIU/ml (95% CI: −2.62, 1.14 µIU/ml; P = 0.44) for fasting insulin concentrations in the fixed-effects model. Subgroup analyses further suggested that the effect of fruit juice on fasting glucose concentrations was not influenced by population region, baseline glucose concentration, duration, type of fruit juice, glycemic index of fruit juice, fruit juice nutrient constitution, total polyphenols dose and Jadad score.
Conclusion
This meta-analysis showed that fruit juice may have no overall effect on fasting glucose and insulin concentrations. More RCTs are warranted to further clarify the association between fruit juice and glycemic control.
Introduction
Diabetes mellitus is now one of the most challenging health problems globally. As reported by the International Diabetes Federation (IDF), more than 371 million people worldwide have diabetes in 2012, and this number is projected to increase to 552 million people by 2030 if no urgent action is taken [1], [2]. In addition, numerous people with impaired glucose tolerance (IGT) or impaired fasting glycaemia (IFG) are at high risk of progressing to type 2 diabetes mellitus (T2DM) [3], [4]. It has been proven that T2DM and its complications are the major cause of disability, reduced quality of life and premature death, imposing a heavy burden on patients and society [5]. Therefore, the importance of efforts to reduce the incidence of diabetes has never been greater.
Accumulating evidence suggests that lifestyle changes, including eating healthy foods can help prevent or delay the development of T2DM [6]–[8]. Fruits are rich in fiber, antioxidants, and phytochemicals that may have beneficial effects on health, and thus are recommended for the primary prevention of T2DM [9]. A recent study also suggested that the consumption of specific whole fruits is related to a significant reduction of T2DM risk [10]. In contrast, evidence on whether fruit juices possess similar protective effects attribute to the whole fruits is still inconclusive [11]–[13]. According to the recommendation by 2010 Dietary Guideline for Americans, fruit juice is considered to be less desirable because it has less dietary fiber than whole fruit [14]. Fruit juice is also criticized by its concentrated or additionally supplemented sugars and contributing the extra calories when consumed in excess [15]. However, Schulze et al. [16] found that fruit fiber was not significantly related to the lower risk of diabetes based on the data of previous prospective studies [17]–[23]. Additionally, it has been demonstrated that although fruit juice is deficient in fiber, other important preventive nutritional components, such as antioxidants and phytochemicals (e.g. polyphenols), are present in fruit juice [24]. In view of these dual properties of fruit juice, great concern has been aroused to identify the effect of fruit juice on T2DM risk. To date, several RCT studies have been conducted to evaluate the association between fruit juicy consumption and glycemic control, but the results have been conflicting. Therefore, we conducted this meta-analysis to synthesize evidence from previous RCTs and provide a more precise estimate of the effect of fruit juice on glucose control and insulin sensitivity based on the PRISMA guidelines.
Methods
Search Strategy
PubMed (updated to March 2014; http://www.ncbi.nlm.nih.gov/pubmed/), Embase (1980 to March 2014; http://www.embase.com/), the Cochrane Library (1985 to March 2014; http://www.cochrane.org/) database, and reference lists and reviews were searched for RCTs designed to assess the effects of fruit juice on glucose control and insulin sensitivity in humans. The structured search strategies used the text words juice or juices limited in abstract/title. The search was restricted to the reports of RCTs in humans (e.g., the search strategy for Embase is: juice:ab,ti OR juices:ab,ti AND [randomized controlled trial]/lim AND [humans]/lim AND [embase]/lim AND [1980–2014]/py).
Study Selection
Studies were selected for this analysis if they 1) were RCTs conducted in human subjects; 2) used a concurrent control group (such as placebo beverage, water, or controlled drink) for the fruit juice treatment group and the difference between the control and treatment group was fruit juice. 3) included subjects ingesting fruit juice for ≥2 wk (to remove acute or very short-term studies); 4) provided the information of baseline and endpoint values or the difference of fasting glucose and insulin concentrations with SD or SEM or 95% CI (when necessary, the authors were contacted to obtain the unavailable data); 5) did not give fruit juice as part of a multi-component supplement.
Quality Assessment
The methodological quality of all studies was evaluated using the following criteria: 1) randomization; 2) double blinding; 3) withdrawals (number and reasons); 4) allocation concealment; and 5) generation of random numbers. One point was given for each area addressed in the study design and the total Jadad score ranges from a minimum of 0 to a maximum of 5 points [25]. The trials with a score of ≥4 were classified as high quality, whereas those receiving a score of <4 were considered as lower quality.
Data Extraction
All data were screened by two investigators (BW and KL) independently with any disagreement resolved by consensus and then collected onto a pre-designed template that included the following items: 1) study characteristics including authors, publication year, sample size, study design, population information, study duration, total polyphenols dose, type of intervention and type of diet; 2) net changes in fasting glucose and insulin concentration, hemoglobin A1c (HbA1c) and the homeostatic model assessment of insulin resistance (HOMA-IR). All values were converted to mmol/L for glucose and µIU/ml for insulin by using conversion factors 1 mg/dL = 0.0556 mmol/L for glucose and 1 pmol/L = 6.945 µIU/ml for insulin concentrations. If primary outcome and secondary outcome concentrations were reported several times in different stages of trials, only values representing the final outcomes at the end of trials were extracted for our meta-analysis.
Statistical Analysis
All statistical analysis in our meta-analysis was performed using STATA, version 11 (StataCorp, College Station, TX, USA). Treatment effects were defined as weighted mean difference (WMD) and 95% CIs in concentrations of fasting glucose and insulin, and values of HbA1c and HOMA-IR. The statistical heterogeneity was examined using Cochran’s test (a P value <0.1 was considered statistically significant) and I 2 tests (I 2>50%, significant heterogeneity) [26]. A random or fixed effects model was used for heterogeneous or non-heterogeneous data, respectively. Nonetheless, fixed effects model was used when less than 5 trials were included in the analysis due to uncertainty in the prediction of heterogeneity [27]. Funnel plots and the Egger’s tests were used to assess the potential publication bias when 10 or more studies were included in meta-analysis.
When not directly available, SD values were calculated from standard errors, 95% CIs, P-values, or t-values. In addition, we assumed a correlation coefficient of 0.5 between baseline and final values, as suggested by Follmann et al [28]. To assess the possible source of heterogeneity between the studies, subgroup analyses were conducted by comparing the study results of population region, baseline glucose concentration, study design, duration, type of fruit juice, glycemic index (GI) of fruit juice, fruit juice nutrient constitution, total polyphenols dose and Jadad score. GI values were obtained from the international GI database [29]. Additional sensitivity analyses were also performed in accordance with the Handbook for Systematic Review of Interventions of Cochrane software (Version 5.0.2; The Cochrane Collaboration, Oxford, UK).
Results
Results of Literature Search
Detailed steps of the literature search are shown in Figure 1 . Of the 2579 initially identified reports, 2528 articles were excluded either because they were duplicate or not relevant to the current meta-analysis. Therefore, 51 potentially relevant articles were further examined. Of these, an additional 39 articles were excluded for the following reasons: 22 articles did not have the data on outcome measures, 9 articles treated the subjects with multi-component supplement, 8 articles did not report enough details of SD or baseline or endpoint or mean difference for primary or secondary outcome measures [30]–[37]. We contacted the main authors of these 8 studies by email, but only one replied and the requested data was no longer available [31]. Thus, 12 articles were finally selected for inclusion in the meta-analysis [38]–[49].
Study Characteristics
The characteristics of trials included in the meta-analysis are shown in Table 1 and Table S1. A total of 12 trials involved 412 subjects and the trials varied in size from 12 to 63 subjects. Total polyphenols content of fruit juice ranged from 341.9 to 2660 mg/d (median: 933.6 mg/d). The study duration varied from 4 wk to 3 mo (median: 7 wk). Seven of 12 RCTs included subjects with hyperglycemia (>110 mg/dL), while the remaining 5 studies selected participants with normal fasting glucose concentrations. Most of the studies (8 of 12) used parallel design. Of the 10 studies which maintained a usual diet, 7 studies suggested the participants avoid the intake of other dietary confounding factors such as wine, green tea or soy products ( Table 1 ). In addition, 10 trials used fruit juice with low GI value (≤55) and the rest 2 studies used median GI fruit juice (56 to 69) [29]. Eight of the 12 included studies reported no significant changes in body weight, and the remaining 4 studies did not report the information of body weight. The participants in all included studies consumed the fruit juices and placebo drinks in the free-living situation. Only 2 studies used ellagic acid, or β-cryptoxanthin plus vitamin C as the biomarkers to evaluate the intervention compliance [45], [48], while 9 studies reported that they have assessed the compliance by periodical in-person interview, or the questionnaire survey, or counting the unconsumed drinks to record the consumption information, etc (Table S1).
Table 1. Characteristics of 12 randomized controlled trials included in analysis.
Study | No. ofsubjects | Country | Studydesign | Participants | Duration | Juice group (Totalpolyphenols; Energy) | Control group | Type of diet |
Reshef 2005 | 12 | Israel | Crossover | Stage I hypertension | 5 wk | 500 ml sweetie fruit juice(444.5 mg/d; NR) | Placebo (low-flavonoidsweetie juice: 115 mg/d) | Usual diet |
Summer 2005 | 39 | US | Parallel | Coronary heart disease | 3 mo | 240 ml pomegranate juice(NR; NR) | Placebo (modifiedsports beverage) | NR |
Bannni 2006 | 23 | US | Parallel | Type 2 diabetes mellitus | 28 d | 150 ml muscadine grapejuice (NR; NR) | No intervention | Usual diet |
Cerda 2006 | 30 | Spain | Parallel | Chronic obstructivepulmonary disease | 5 wk | 400 ml pomegranate juice(2660 mg/d; NR) | Placebo (synthetic orangeflavoured drink) | Controlled diet, limit berries, pomegranates,chocolate, nuts and wine |
Hollis 2010 | 51 | US | Parallel | Overweight | 12 wk | 480 ml concord grapejuice (933.6 mg/d; 350 kcal/d) | Placebo (grape-flavored drink) | Usual diet, avoid the intake of other juices |
Basu 2010a | 48 | US | Parallel | Metabolic syndrome | 8 wk | 50 g freeze-dried blueberryjuice (1624 mg/d; 174 kcal/d) | Water (similar fluid intake) | Usual diet, avoid the intake of other berries,green tea, cocoa, and soy |
Dohadwala 2010 | 63 | US | Crossover | Stage I hypertension | 8 wk | 490 ml concord grape juice(965 mg/d; 327 kcal/d) | Placebo beverage | Usual diet, avoid the intake of grape juice,wine, grape products, green or black tea,dark juices |
Basu 2010b | 27 | US | Parallel | Metabolic syndrome | 8 wk | 50 g freeze-dried strawberryjuice (2160 mg/d; 150 kcal/d) | Water (similar fluid intake) | Usual diet, avoid the intake of other berries |
Gonzalez-Ortiz 2011 | 20 | US | Parallel | Obesity | 1 mo | 120 ml pomegranate juice(NR; NR) | Placebo (NR) | Usual diet |
Dohadwala 2011 | 44 | US | Crossover | Coronary artery disease | 4 wk | 480 ml cranberry juice(835 mg/d; NR) | Placebo beverage(no polyphenols) | Usual diet, avoid the intake of grape juice,wine, grape products, green or black tea,dark juices |
Morand 2011 | 24 | France | Crossover | Overweight | 4 wk | 500 ml orange juice(341.9 mg/d; 194 kcal/d) | Control drink (only containsmatched sugar composition) | Usual diet, avoid the intake of citrus-containing foods and limit tea, coffee,cocoa, wine, fruit juice ≤200 mL/d |
Basu 2011 | 31 | US | Parallel | Metabolic syndrome | 8 wk | 240 ml low-energy cranberryjuice (458 mg/d; 167 kcal/d) | Placebo (polyphenol-free) | Usual diet, avoid the intake of berries,green tea, cocoa, and soy products |
The studies by Reshef (2005), Cerda (2006), Hollis (2010), Dohadwala (2010), Dohadwala (2011), and Basu (2011) used fruit juice with polyphenols as main nutrients, and the studies by Summer (2005), Bannni (2006), Basu (2010a), Basu (2010b), Gonzalez-Ortiz (2011), and Morand (2011) used fruit juice with multi-nutrients (polyphenols, vitamins, and sugar et al.); a usual diet was similar to a conventional diet.
NR, not reported.
Data Quality
Study qualities of the selected trials were assessed by the Jadad scale [25], and the results were diverse. Six trials were classified as high quality (Jadad score ≥4) [39], [41], [42], [44], [48], [49], and the remaining 6 trials were classified as low quality (Jadad score <4). All of the 6 high-quality trials had the clearly adequate allocation concealment (ie, allocated by a third party or used opaque envelopes), and 2 high-quality trials reported the generation of random numbers or randomization list. The details of dropouts were reported in 10 trials [38],[39],[41]–[45],[47]–[49].
Effect of Fruit Juice on Glucose Control and Insulin Sensitivity
As shown in Table 2 , fruit juice did not significantly affect the concentrations of fasting glucose, fasting insulin and HbA1c, while it significantly increased the HOMA-IR values. No significant heterogeneity was found in the concentrations of fasting glucose, fasting insulin and HbA1c. Significant heterogeneity was noted in the results of HOMA-IR (P = 0.01). For the 12 trials that reported data on fasting glucose concentration, no significant mean differences was found in the subjects supplemented with fruit juice (0.79 mg/dL; 95% CI: −1.44, 3.02 mg/dL; P = 0.49; Figure 2 ) compared with control subjects. The mean difference change in fasting insulin concentrations was reported in 5 trials and found to be not significantly different (−0.74 µIU/ml; 95% CI: −2.62, 1.14 mg/dL; P = 0.44; Figure 3 ). In addition, the results of the effects of fruit juice on HbA1c concentrations and HOMA-IR values were −0.03% (95% CI: −0.28, 0.23%; P = 0.84) and 0.59 (95% CI: 0.20, 0.97; P<0.01), respectively ( Figure 4 and Figure 5 ).
Table 2. Pooled effects of fruit juice on fasting glucose, fasting insulin, HbA1c and HOMA-IR levels.
Variable | No. of studies | Sample size (treatment/control) | Net change (95% CI) | P | Test of heterogeneity | |
P | I2,% | |||||
Fasting glucose (mg/dL) | 12 | 279/276 | 0.79 (−1.44, 3.02) | 0.49 | 0.68 | 0.0 |
Fasting insulin (µIU/ml) | 5 | 149/156 | −0.74 (−2.62, 1.14) | 0.44 | 0.48 | 0.0 |
HbA1c (%) | 3 | 56/54 | −0.03 (−0.28, 0.23) | 0.84 | 0.20 | 38.5 |
HOMA-IR (units) | 3 | 121/119 | 0.59 (0.20, 0.97) | <0.01 | 0.01 | 77.2 |
HbA1c, hemoglobin A1c; HOMA-IR, the homeostatic model assessment of insulin resistance.
Subgroup and Sensitivity Analysis
Pre-specified subgroup analyses showed that the pooled effects of fruit juice on fasting glucose concentrations were not influenced by population region, baseline glucose concentration, duration, type of fruit juice, GI values of fruit juice, fruit juice nutrient constitution, total polyphenols dose and Jadad score. The consumption of fruit juice significantly increased fasting glucose concentrations in parallel-design groups. Results are presented in Table 3 . Sensitivity analysis showed that the pooled effects of fruit juice on fasting glucose were not altered when analyses were limited to high-quality studies and were not changed after imputation using a correlation coefficient of 0.5. In addition, we found no significant change of outcome measures through systematic removal of each trial during sensitivity analysis.
Table 3. Subgroup analyses of fasting glucose stratified by previously defined study characteristics.
Variables | Fasting glucose | ||||
No. of trials | Net change(95% CI) | Test of heterogeneity | P | ||
P | I2,% | ||||
Subgroup analysis | |||||
Region | |||||
US | 9 | 0.95 (−1.15, 3.36) | 0.43 | 0.5 | 0.44 |
European | 2 | −1.25 (−10.72, 8.22) | 0.73 | 0.0 | 0.80 |
Asia | 1 | 0.50 (−7.24, 8.24) | – | – | 0.90 |
Baseline glucose concentration | |||||
<110 mg/dL (normal glucose) | 7 | 1.03 (−1.29, 3.42) | 0.39 | 5.9 | 0.60 |
>110 mg/dL (hyperglycemia) | 4 | −2.19 (−10.46, 6.08) | 0.95 | 0.0 | 0.39 |
Study design | |||||
Parallel | 8 | 3.48 (0.44, 6.53) | 0.84 | 0.0 | 0.03 |
Crossover | 4 | −2.53 (−5.63, 0.94) | 0.99 | 0.0 | 0.16 |
Duration | |||||
<7 wk (low median) | 6 | 0.92 (−2.88, 4.72) | 0.94 | 0.0 | 0.64 |
≥7 wk (high median) | 6 | 0.72 (−1.44, 3.02) | 0.21 | 29.9 | 0.61 |
Type of fruit juice | |||||
Berries juice | 4 | 3.28 (−1.05, 7.61) | 0.73 | 0.0 | 0.14 |
Grapes juice | 3 | −0.56 (−3.82, 2.69) | 0.09 | 57.7 | 0.74 |
Pomegranate juice | 3 | 1.77 (−4.39, 7.93) | 0.98 | 0.0 | 0.57 |
Orange juice | 1 | −1.80 (−11.78, 8.18) | – | – | 0.72 |
Glycemic index of fruit juice | |||||
Low glycemic index (≤55) | 10 | 0.24 (−2.19, 2.67) | 0.75 | 0.0 | 0.85 |
Medium glycemic index (56–69) | 2 | 3.71 (−1.90, 9.32) | 0.28 | 14.0 | 0.20 |
Fruit juice nutrient constitution | |||||
Multi-nutrients | 6 | 1.73 (−2.00, 5.47) | 0.98 | 0.0 | 0.36 |
Polyphenols (main nutrients) | 6 | 0.27 (−2.51, 3.05) | 0.20 | 31.0 | 0.85 |
Total polyphenols dose | |||||
<933.6 mg/d (low median) | 6 | 2.60 (−0.81, 6.01) | 0.13 | 0.0 | 0.69 |
≥933.6 mg/d (high median) | 3 | −0.78 (−4.06, 2.50) | 0.28 | 0.0 | 0.45 |
Jadad score | |||||
Low (<4) | 6 | 1.69 (−1.85, 5.23) | 0.96 | 0.0 | 0.35 |
High (≥4) | 6 | 0.20 (−2.67, 3.07) | 0.23 | 27.8 | 0.89 |
Publication Bias
The shape of funnel plot for the studies on fruit juice and fasting glucose did not show obvious publication bias ( Figure 6 ). Similarly, no evidence of publication bias was observed by Egger’s test (P = 0.50). Publication bias of the studies on fasting insulin, HbA1c and HOMA-IR was not assessed owing to the limited numbers of studies currently available (n = 5, 3 and 3, respectively).
Discussion
Our meta-analysis showed that fruit juice consumption did not significantly affect fasting glucose and insulin concentrations. Subgroup analyses further suggested that the pooled mean difference changes of fasting glucose concentrations were not significantly influenced by the population region, baseline glucose concentration, duration, type of fruit juice, GI values of fruit juice, fruit juice nutrient constitution and total polyphenols dose, and the outcome remained non-significant when analyses were limited to high quality studies. Our assessment of the effects of fruit juice on HbA1c and HOMA-IR values was limited by the small number of studies currently available.
As one of the most popular beverages, the global consumption of fruit juice has been steadily increased in recent years, probably due to the public perception of fruit juice as a natural source of nutrients [50]. It has been demonstrated that the polyphenols contained in fruit juice can improve the antioxidant status and immune function of the participants, thus may have beneficial effect in reducing the risk of cancer and cardiovascular disease [51], [52]. However, the role of fruit juice consumption on diabetes control has not been well studied and the result remains inconclusive. In this meta-analysis study, we found that fruit juice had no significant effects on fasting glucose and insulin concentrations. One possibility is that fruit juice has less fiber than whole fruit, and a previous meta-analysis indicated that increasing consumption of dietary fibers can reduce fasting glucose concentration and HbA1C [53]. Another possibility is that fruit juice intervention might modestly increase the participants’ dietary consumption of sugars and energy, which may influence the total effects of fruit juice on glucose control since most of the trials suggested that the participants maintained their usual diet during the intervention duration. In addition, previous studies suggested that fruit juice consumption had no significant favorable effect on lipid abnormalities, which often clusters with insulin resistance [54], [55]. Therefore, the effects of fruit juice on glycemic control in this study might be mildly underestimated, since the participants in the majority of the selected studies (10/12) had abnormal lipid profiles [38], [40]–[46], [48], [49].
We found that fruit juice intake significantly increased fasting glucose concentrations when we pooled the data of the parallel-design RCTs. However, this increasing effect might not be clinically significant since the participants in most selected parallel-design studies (6 of 8) had normal baseline glucose concentration, which can lead to a certain glucose fluctuation in the normal regulation of glucose homeostasis [56]. Therefore, we conducted an additional subgroup analysis using parallel-design trials which included participants with abnormal baseline glucose concentration, and the result suggested that fruit juice does not increase glucose concentration (P = 0.90). This result partly supported our inference, although it had less statistical power since only 2 trials were included in this subgroup analysis. In addition, we consistently found that fruit juice consumption had no significant effects on increasing glucose, when we conducted subgroup meta-analyses by the other variables, such as population region, baseline glucose concentration, duration, type of fruit juice, fruit juice nutrient constitution, total polyphenols dose or Jadad score. On the other hand, we also found that fruit juice could significantly increase the HOMA-IR values using the fixed effects model. However, the result is limited by the significant heterogeneity (P = 0.01) and the small number of available trials (n = 3). In addition, we found that fruit juice had no significant effects on HOMA-IR values when we used the random effects model (P = 0.87). For these reasons, whether fruit juice can affect the insulin sensitivity should be further evaluated.
It is suggested that the GI values indicate the extent of glycemic response to carbohydrate ingestion [57] and vary among different fruit juices [29]. To evaluate whether the GI values affects the association between fruit juice and glycemic control, we further investigated the effects of GI levels of fruit juices on fasting glucose concentrations. Our study indicated that neither low GI fruit juices nor medium GI fruit juices had significantly effect on fasting glucose concentrations. Since no selected RCTs used fruit juice with high GI as supplement, we could not evaluate the effect of high GI fruit juice on fasting glucose concentrations. In addition, this result was further limited because none of the selected 12 trials reported the GI values of the fruit juices they used. To minimize the difference between estimated and actual GI values, we indirectly obtained the most proximate GI values from the online GI database according to the types of respective fruit juices [29], and subsequently classified them in a certain range (low GI fruit juice, ≤55; medium GI fruit juice, 56–69) in the subgroup analysis. Consequently, more high-quality RCTs focused on the association between GI values of fruit juice and glycemic control are needed to further assess these causal conclusions.
To our knowledge, this is the first study to systematically review the potential effects of fruit juice on glycemic control. The relatively large amount of pooled participants possesses a greater statistical power than small number of subjects in a single RCT. However, some limitations should be addressed when interpreting the findings of this study.
At first, explicit doses of sugars, artificial flavoring agents and vitamins were unavailable in most of selected studies and the total polyphenols doses of fruit juice ranged from 341.9 to 2660 mg/d (median: 933.6 mg/d). Although the wide range of total-polyphenols dose did not result in the significant heterogeneity in our study, this might affect the overall outcomes of the meta-analysis.
Secondly, only 1 study excluded subjects with weight-reducing dietary regimen [41], and the remaining 11 did not report the information on the advice of losing weight. Ten of the 12 studies advocated that fruit juice was added to the usual diet, which might increase energy content of the diet and body weight of the participants. Nonetheless, 8 of the included studies reported non-significant changes in body weight and the remaining 4 studies did not report the related information. This potential discrepancy may partly due to the controlled amount of fruit juice suggested by the investigators (120–500 ml, or 50 g freeze-dried powders), which prevented the excess extra energy intake (150–350 kcal/d; information provided by 6 studies, [42]–[45], [48], [49]) of the participants. However, we could not further evaluate the association between fruit juice intake and body weight change owing to the limited available information on dietary structure, total energy intake and daily physical activities, etc. In addition, we could not conduct further subgroup analyses on the fasting insulin concentration, HbA1c and HOMA-IR due to the small number of available RCTs.
Thirdly, measures for glucose control or insulin sensitivity were not primary outcomes in some RCTs included in this meta-analysis and the null findings of secondary outcomes may not have always been published. In addition, although only randomized controlled trials were selected for our analysis which are inherently less susceptible to bias, the results synthesized from the 12 RCTs are still limited by their varied study qualities (from low to high), relatively small sample sizes (from 12 to 63) and short period of follow-up (from 4 wk to 3 mo). Moreover, only 2 studies used objective measures such as ellagic acid, or β-cryptoxanthin plus vitamin C to evaluate the intervention compliance [45], [48].
In conclusion, our study showed that the consumption of fruit juice may have no significant effect on fasting glucose and insulin concentrations. To further advance this area, future high-quality RCTs with adequate sample size and long follow-up periods are needed to evaluate and confirm the effect of fruit juice on glucose control and insulin sensitivity, particularly in the patients with hyperglycemia. To improve the quality of study, investigators should ensure and objectively evaluate the compliance, and use the appropriate blinding methods, control group and matched placebo. In addition, the result will be more convincing if they can effectively rule out the confounding effect of extra energy provided by fruit juice on body weight and other related measures.
Supporting Information
Acknowledgments
We thank Dr. Jennifer H. McKenzie at Harvard Medical School for proofreading the manuscript.
Funding Statement
The Science Key Research Project of Chongqing Science and Technology Commission (grant number: CSTC, 2011AB5040) and “the 12th Five year Plan” for National Key Technology Research and Development Program (grant number: 2012BAI35B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94: 311–321. [DOI] [PubMed] [Google Scholar]
- 2. Guariguata L (2012) By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract 98: 524–525. [DOI] [PubMed] [Google Scholar]
- 3. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, et al. (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78: 305–312. [DOI] [PubMed] [Google Scholar]
- 4. Sherwin R, Jastreboff AM (2012) Year in diabetes 2012: The diabetes tsunami. J Clin Endocrinol Metab 97: 4293–4301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Global status report on noncommunicable diseases 2010. Geneva, World Health Organization, 2011.
- 6. Lindstrom J, Peltonen M, Eriksson JG, Aunola S, Hamalainen H, et al. (2008) Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care 31: 857–862. [DOI] [PubMed] [Google Scholar]
- 7. Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, et al. (2011) Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med 155: 292–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C (2013) Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes: A Systematic Review and Meta-analysis. Ann Intern Med 159: 543–551. [DOI] [PubMed] [Google Scholar]
- 9.World Health Organization. Promoting fruit and vegetable consumption around the world. 2003. www.who.int/dietphysicalactivity/fruit/en/index.html.
- 10. Muraki I, Imamura F, Manson JE, Hu FB, Willett WC, et al. (2013) Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ 347: f5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Bazzano LA, Li TY, Joshipura KJ, Hu FB (2008) Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 31: 1311–1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Pereira MA, Fulgoni VL III (2010) Consumption of 100% fruit juice and risk of obesity and metabolic syndrome: findings from the national health and nutrition examination survey 1999–2004. J Am Coll Nutr 29: 625–629. [DOI] [PubMed] [Google Scholar]
- 13. Eshak ES, Iso H, Mizoue T, Inoue M, Noda M, et al. (2013) Soft drink, 100% fruit juice, and vegetable juice intakes and risk of diabetes mellitus. Clin Nutr 3: 300–308. [DOI] [PubMed] [Google Scholar]
- 14.U.S. Department of Agriculture and U.S. Department of Health and Human Services (2010) Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: U.S. Government Printing Office. 35–36. [DOI] [PMC free article] [PubMed]
- 15. Wang YC, Bleich SN, Gortmaker SL (2008) Increasing caloric contribution from sugar-sweetened beverages and 100% fruit juices among US children and adolescents, 1988–2004. Pediatrics 121: e1604–e1614. [DOI] [PubMed] [Google Scholar]
- 16. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, et al. (2007) Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis. Arch Intern Med 167: 956–965. [DOI] [PubMed] [Google Scholar]
- 17. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, et al. (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277: 472–477. [DOI] [PubMed] [Google Scholar]
- 18. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, et al. (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20: 545–550. [DOI] [PubMed] [Google Scholar]
- 19. Meyer KA, Kushi LH, Jacobs DR Jr, Slavin J, Sellers TA, et al. (2000) Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71: 921–930. [DOI] [PubMed] [Google Scholar]
- 20. Stevens J, Ahn K, Juhaeri, Houston D, Steffan L, et al. (2002) Dietary fiber intake and glycemic index and incidence of diabetes in African-American and white adults: the ARIC study. Diabetes Care 25: 1715–1721. [DOI] [PubMed] [Google Scholar]
- 21. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A (2003) Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77: 622–629. [DOI] [PubMed] [Google Scholar]
- 22. Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, et al. (2004) Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 80: 348–356. [DOI] [PubMed] [Google Scholar]
- 23. Hodge AM, English DR, O’Dea K, Giles GG (2004) Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 27: 2701–2706. [DOI] [PubMed] [Google Scholar]
- 24. Ruxton CH, Gardner EJ, Walker D (2006) Can pure fruit and vegetable juices protect against cancer and cardiovascular disease too? A review of the evidence. Int J Food Sci Nutr 57: 249–272. [DOI] [PubMed] [Google Scholar]
- 25. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, et al. (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 352: 609–613. [DOI] [PubMed] [Google Scholar]
- 26. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Higgins JP, Thompson SG, Spiegelhalter DJ (2009) A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 172: 137–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Follmann D, Elliott P, Suh I, Cutler J (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45: 769–773. [DOI] [PubMed] [Google Scholar]
- 29.University of Sydney. Online glycemic index database. Available: www.glycemicindex.com/. Accessed 2014 March 29.
- 30. Krikorian R, Nash TA, Shidler MD, Shukitt-Hale B, Joseph JA (2010) Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr 103: 730–4. [DOI] [PubMed] [Google Scholar]
- 31. Fujioka K, Greenway F, Sheard J, Ying Y (2006) The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J Med Food 9: 49–54. [DOI] [PubMed] [Google Scholar]
- 32. Buscemi S, Rosafio G, Arcoleo G, Mattina A, Canino B, et al. (2012) Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. Am J Clin Nutr 95: 1089–95. [DOI] [PubMed] [Google Scholar]
- 33. Milenkovic D, Deval C, Dubray C, Mazur A, Morand C (2011) Hesperidin displays relevant role in the nutrigenomic effect of orange juice on blood leukocytes in human volunteers: a randomized controlled cross-over study. PLOS ONE 6: e26669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Davidson MH, Maki KC, Dicklin MR, Feinstein SB, Witchger M, et al. (2009) Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104: 936–42. [DOI] [PubMed] [Google Scholar]
- 35. Lamprecht M, Oettl K, Schwaberger G, Hofmann P, Greilberger JF (2007) Several indicators of oxidative stress, immunity, and illness improved in trained men consuming an encapsulated juice powder concentrate for 28 weeks. J Nutr 137: 2737–41. [DOI] [PubMed] [Google Scholar]
- 36. Mollace V, Sacco I, Janda E, Malara C, Ventrice D, et al. (2011) Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia 82: 309–16. [DOI] [PubMed] [Google Scholar]
- 37. Dalgard C, Nielsen F, Morrow JD, Enghusen-Poulsen H, Jonung T, et al. (2009) Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br J Nutr 101: 263–9. [DOI] [PubMed] [Google Scholar]
- 38. Reshef N, Hayari Y, Goren C, Boaz M, Madar Z, et al. (2005) Antihypertensive effect of sweetie fruit in patients with stage I hypertension. Am J Hypertens 18: 1360–1363. [DOI] [PubMed] [Google Scholar]
- 39. Sumner MD, Elliott-Eller M, Weidner G, Daubenmier JJ, Chew MH, et al. (2005) Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol 96: 810–814. [DOI] [PubMed] [Google Scholar]
- 40. Banini AE, Boyd LC, Allen JC, Allen HG, Sauls DL (2006) Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects. Nutrition 22: 1137–1145. [DOI] [PubMed] [Google Scholar]
- 41. Cerda B, Soto C, Albaladejo MD, Martinez P, Sanchez-Gascon F, et al. (2006) Pomegranate juice supplementation in chronic obstructive pulmonary disease: a 5-week randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 60: 245–253. [DOI] [PubMed] [Google Scholar]
- 42. Hollis JH, Houchins JA, Blumberg JB, Mattes RD (2009) Effects of concord grape juice on appetite, diet, body weight, lipid profile, and antioxidant status of adults. J Am Coll Nutr 28: 574–582. [DOI] [PubMed] [Google Scholar]
- 43. Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, et al. (2010) Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 140: 1582–1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Dohadwala MM, Hamburg NM, Holbrook M, Kim BH, Duess MA, et al. (2010) Effects of Concord grape juice on ambulatory blood pressure in prehypertension and stage 1 hypertension. Am J Clin Nutr 92: 1052–1059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Basu A, Fu DX, Wilkinson M, Simmons B, Wu M, et al. (2010) Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res 30: 462–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Gonzalez-Ortiz M, Martinez-Abundis E, Espinel-Bermudez MC, Perez-Rubio KG (2011) Effect of pomegranate juice on insulin secretion and sensitivity in patients with obesity. Ann Nutr Metab 58: 220–223. [DOI] [PubMed] [Google Scholar]
- 47. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, et al. (2011) Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 93: 934–940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, et al. (2011) Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 93: 73–80. [DOI] [PubMed] [Google Scholar]
- 49. Basu A, Betts NM, Ortiz J, Simmons B, Wu M, et al. (2011) Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res 31: 190–196. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Franke AA, Cooney RV, Henning SM, Custer LJ (2005) Bioavailability and antioxidant effects of orange juice components in humans. J Agric Food Chem 53: 5170–5178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Bub A, Watzl B, Blockhaus M, Briviba K, Liegibel U, et al. (2003) Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J Nutr Biochem 14: 90–98. [DOI] [PubMed] [Google Scholar]
- 52. Miglio C, Peluso I, Raguzzini A, Villano DV, Cesqui E, et al. (2014) Fruit juice drinks prevent endogenous antioxidant response to high-fat meal ingestion. Br J Nutr 111: 294–300. [DOI] [PubMed] [Google Scholar]
- 53. Post RE, Mainous AG 3rd, King DE, Simpson KN (2012) Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis. J Am Board Fam Med 25: 16–23. [DOI] [PubMed] [Google Scholar]
- 54. Liu K, Xing A, Chen K, Wang B, Zhou R, et al. (2013) Effect of fruit juice on cholesterol and blood pressure in adults: a meta-analysis of 19 randomized controlled trials. PLOS ONE 8: e61420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, et al. (2007) Lipid mediators of insulin resistance. Nutr Rev 65: S39–46. [DOI] [PubMed] [Google Scholar]
- 56. Punthakee Z (2013) Role of the laboratory in diabetes diagnosis and screening–the 2013 CDA CPGs. Clin Biochem 46: 707–709. [DOI] [PubMed] [Google Scholar]
- 57. Sieri S, Brighenti F, Agnoli C, Grioni S, Masala G, et al. (2013) Dietary glycemic load and glycemic index and risk of cerebrovascular disease in the EPICOR cohort. PLOS ONE 8: e62625. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.